Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Predominant previous polarity as an outcome predictor in a controlled treatment trial for depression in bipolar I disorder patients.

Vieta E, Berk M, Wang W, Colom F, Tohen M, Baldessarini RJ.

J Affect Disord. 2009 Dec;119(1-3):22-7. doi: 10.1016/j.jad.2009.02.028. Epub 2009 Mar 26.

PMID:
19324419
2.

Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.

Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M.

J Clin Psychiatry. 2009 Oct;70(10):1424-31. doi: 10.4088/JCP.08m04772gre.

PMID:
19906346
3.

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.

Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, Mitchell PB, Centorrino F, Risser R, Baker RW, Evans AR, Beymer K, Dube S, Tollefson GD, Breier A.

Arch Gen Psychiatry. 2003 Nov;60(11):1079-88. Erratum in: Arch Gen Psychiatry. 2004 Feb;61(2):176.

PMID:
14609883
4.

Genetic association study of treatment response with olanzapine/fluoxetine combination or lamotrigine in bipolar I depression.

Perlis RH, Adams DH, Fijal B, Sutton VK, Farmen M, Breier A, Houston JP.

J Clin Psychiatry. 2010 May;71(5):599-605. doi: 10.4088/JCP.08m04632gre. Epub 2009 Dec 15.

PMID:
20021991
5.

A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression.

Corya SA, Perlis RH, Keck PE Jr, Lin DY, Case MG, Williamson DJ, Tohen MF.

J Clin Psychiatry. 2006 May;67(5):798-806.

PMID:
16841630
6.

Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials.

Szegedi A, Zhao J, van Willigenburg A, Nations KR, Mackle M, Panagides J.

BMC Psychiatry. 2011 Jun 20;11:101. doi: 10.1186/1471-244X-11-101.

7.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
8.

A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression.

Brown EB, McElroy SL, Keck PE Jr, Deldar A, Adams DH, Tohen M, Williamson DJ.

J Clin Psychiatry. 2006 Jul;67(7):1025-33.

PMID:
16889444
9.

Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.

Houston JP, Tohen M, Degenhardt EK, Jamal HH, Liu LL, Ketter TA.

J Clin Psychiatry. 2009 Nov;70(11):1540-7. doi: 10.4088/JCP.08m04895yel. Epub 2009 Sep 22. Erratum in: J Clin Psychiatry. 2011 Aug;72(8):1157. J Clin Psychiatry. 2010 Jan;71(1):93.

PMID:
19778495
10.

Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression.

Keck PE Jr, Corya SA, Altshuler LL, Ketter TA, McElroy SL, Case M, Briggs SD, Tohen M.

J Clin Psychiatry. 2005 May;66(5):611-6.

PMID:
15889948
11.

Olanzapine/Fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial.

Detke HC, DelBello MP, Landry J, Usher RW.

J Am Acad Child Adolesc Psychiatry. 2015 Mar;54(3):217-24. doi: 10.1016/j.jaac.2014.12.012. Epub 2014 Dec 29.

12.

Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trial.

Shi L, Namjoshi MA, Swindle R, Yu X, Risser R, Baker RW, Tohen M.

Clin Ther. 2004 Jan;26(1):125-34. Erratum in: Clin Ther. 2004 Nov;26(11):1934.

PMID:
14996525
13.

Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression.

Brown E, Dunner DL, McElroy SL, Keck PE, Adams DH, Degenhardt E, Tohen M, Houston JP.

Int J Neuropsychopharmacol. 2009 Jul;12(6):773-82. doi: 10.1017/S1461145708009735. Epub 2008 Dec 11.

PMID:
19079815
14.

Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.

Niufan G, Tohen M, Qiuqing A, Fude Y, Pope E, McElroy H, Ming L, Gaohua W, Xinbao Z, Huichun L, Liang S.

J Affect Disord. 2008 Jan;105(1-3):101-8. Epub 2007 May 24.

PMID:
17531327
16.

Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data.

Vieta E, Calabrese JR, Hennen J, Colom F, Martínez-Arán A, Sánchez-Moreno J, Yatham LN, Tohen M, Baldessarini RJ.

J Clin Psychiatry. 2004 Oct;65(10):1420-8.

PMID:
15491248
17.

Early improvement as a predictor of acute treatment outcome in manic or mixed episodes in bipolar-1 disorder: a pooled, post hoc analysis from the asenapine development program.

Szegedi A, Zhao J, McIntyre RS.

J Affect Disord. 2013 Sep 25;150(3):745-52. doi: 10.1016/j.jad.2013.01.024. Epub 2013 Mar 6.

PMID:
23473546
18.
19.

Clinical relevance of depressive symptom improvement in bipolar I depressed patients.

Williamson D, Brown E, Perlis RH, Ahl J, Baker RW, Tohen M.

J Affect Disord. 2006 Jun;92(2-3):261-6. Epub 2006 Mar 24.

PMID:
16563521
20.

Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial.

Perlis RH, Baker RW, Zarate CA Jr, Brown EB, Schuh LM, Jamal HH, Tohen M.

J Clin Psychiatry. 2006 Nov;67(11):1747-53.

PMID:
17196055

Supplemental Content

Support Center